BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 9479631)

  • 1. Evidence for a significant role of gastrin in cysteamine-induced hypersecretion of gastric acid.
    Shiratori K; Shimizu K; Ikeda M; Watanabe S; Hayashi N
    J Clin Gastroenterol; 1997; 25 Suppl 1():S84-8. PubMed ID: 9479631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CCK1 and CCK2 receptors regulate gastric pepsinogen secretion.
    Blandizzi C; Lazzeri G; Colucci R; Carignani D; Tognetti M; Baschiera F; Del Tacca M
    Eur J Pharmacol; 1999 May; 373(1):71-84. PubMed ID: 10408253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of antisecretory and antiulcer activity of CR 2945, a new potent and selective gastrin/CCK(B) receptor antagonist.
    Makovec F; Revel L; Letari O; Mennuni L; Impicciatore M
    Eur J Pharmacol; 1999 Mar; 369(1):81-90. PubMed ID: 10204685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contribution of gastrin to cysteamine-induced gastric acid secretion in rats.
    van de Brug FJ; Jansen JB; Kuijpers IJ; Lamers CB
    Life Sci; 1993; 52(23):1861-7. PubMed ID: 8502123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of gastrin- and histamine-stimulated gastric acid secretion by gastrin and cholecystokinin antagonists in the rat.
    Hirst BH; Elliott KJ; Ryder H; Szelke M
    Aliment Pharmacol Ther; 1991 Feb; 5(1):31-9. PubMed ID: 1932479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. YF476 is a new potent and selective gastrin/cholecystokinin-B receptor antagonist in vitro and in vivo.
    Takinami Y; Yuki H; Nishida A; Akuzawa S; Uchida A; Takemoto Y; Ohta M; Satoh M; Semple G; Miyata K
    Aliment Pharmacol Ther; 1997 Feb; 11(1):113-20. PubMed ID: 9042983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cholecystokinin type B receptor antagonist PD-136,450 is a partial secretory agonist in the stomach and a full agonist in the pancreas of the rat.
    Schmassmann A; Garner A; Flogerzi B; Hasan MY; Sanner M; Varga L; Halter F
    Gut; 1994 Feb; 35(2):270-4. PubMed ID: 8307482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The gastrin/cholecystokinin-B receptor antagonist L-365,260 reduces basal acid secretion and prevents gastrointestinal damage induced by aspirin, ethanol and cysteamine in the rat.
    Pendley CE; Fitzpatrick LR; Ewing RW; Molino BF; Martin GE
    J Pharmacol Exp Ther; 1993 Jun; 265(3):1348-54. PubMed ID: 8510013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CCK-B (gastrin) receptor regulates gastric histamine release and acid secretion.
    Sandvik AK; Waldum HL
    Am J Physiol; 1991 Jun; 260(6 Pt 1):G925-8. PubMed ID: 1711780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of cholecystokinin receptor antagonists, MK-329 and L-365,260, on cholecystokinin-induced acid secretion and histidine decarboxylase activity in the rat.
    Kawabata S; Kanayama S; Shinomura Y; Miyazaki Y; Imamura I; Moriwaki K; Wada H; Tarui S
    Regul Pept; 1991 Jul; 35(1):1-10. PubMed ID: 1924892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biological activity of carboxy-terminal gastrin analogs.
    Sandvik AK; Dockray GJ
    Eur J Pharmacol; 1999 Jan; 364(2-3):199-203. PubMed ID: 9932724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [An experimental study of adrenalin-stimulated gastric acid secretion and gastrin secretion in rats of cysteamine-induced duodenal ulcer].
    Koga S; Kashiwagi H; Aoki T
    Nihon Shokakibyo Gakkai Zasshi; 1992 Mar; 89(3):580-7. PubMed ID: 1578802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of cionin on histamine and acid secretion by the perfused rat stomach.
    MÃ¥rvik R; Johnsen AH; Rehfeld JF; Sandvik A; Waldum HL
    Scand J Gastroenterol; 1994 Jul; 29(7):591-4. PubMed ID: 7524136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Attenuation of gastrin-induced gastric acid secretion by antisense oligonucleotide to the CCKB/gastrin receptor.
    Rao RK; Lopez Y; Lai J; Riviere PJ; Junien JL; Porreca F
    Neuroreport; 1995 Nov; 6(17):2373-7. PubMed ID: 8747156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of YF476, a potent and selective gastrin/cholecystokinin-B receptor antagonist, on gastric acid secretion in beagle dogs with gastric fistula.
    Takemoto Y; Yuki H; Nishida A; Ito H; Kobayashi-Uchida A; Takinami Y; Akuzawa S; Ohta M; Satoh M; Semple G; Miyata K
    Arzneimittelforschung; 1998 Apr; 48(4):403-7. PubMed ID: 9608884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. YM022, a highly potent and selective CCKB antagonist inhibiting gastric acid secretion in the rat, the cat and isolated rabbit glands.
    Attoub S; Moizo L; Laigneau JP; Alchepo B; Lewin MJ; Bado A
    Fundam Clin Pharmacol; 1998; 12(3):256-62. PubMed ID: 9646057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of muscarinic and beta-adrenergic blockade on cysteamine-induced gastrin secretion by the isolated perfused rat stomach.
    McIntosh CH; Bakich V; Kwok YN; Brown JC
    Life Sci; 1987 Sep; 41(13):1615-20. PubMed ID: 3041147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of S-0509, a novel CCKB/gastrin receptor antagonist, on acid secretion and experimental duodenal ulcers in rats.
    Takeuchi K; Hirata T; Yamamoto H; Kunikata T; Ishikawa M; Ishihara Y
    Aliment Pharmacol Ther; 1999 Jan; 13(1):87-96. PubMed ID: 9892884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of gastrin and cholecystokinin receptors in regulation of peptone-stimulated gastric acid secretion in conscious rats.
    Varga G; Campbell DR; Bussjaeger LJ; Solomon TE
    Eur J Pharmacol; 1993 Nov; 250(1):37-42. PubMed ID: 8119323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of cholecystokinin in the inhibition of gastric acid secretion in dogs.
    Konturek SJ; Bilski J; Tasler J; Cieszkowski M
    J Physiol; 1992; 451():477-89. PubMed ID: 1403819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.